USANA Health Sciences, Inc. (NYSE:USNA) insider Walter Noot sold 363 shares of the business’s stock in a transaction dated Thursday, November 8th. The stock was sold at an average price of $119.50, for a total transaction of $43,378.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
NYSE USNA traded up $2.83 on Friday, hitting $119.56. 303,824 shares of the company were exchanged, compared to its average volume of 195,357. The company has a market cap of $2.89 billion, a PE ratio of 29.45 and a beta of 0.80. USANA Health Sciences, Inc. has a twelve month low of $64.70 and a twelve month high of $137.95.
USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, October 23rd. The company reported $1.24 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.14. The firm had revenue of $296.80 million for the quarter, compared to the consensus estimate of $289.54 million. USANA Health Sciences had a return on equity of 30.37% and a net margin of 7.57%. The business’s revenue for the quarter was up 13.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.03 EPS. On average, research analysts forecast that USANA Health Sciences, Inc. will post 4.9 earnings per share for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC raised its holdings in USANA Health Sciences by 7.3% during the 2nd quarter. Renaissance Technologies LLC now owns 2,105,466 shares of the company’s stock worth $242,760,000 after buying an additional 144,000 shares during the period. BlackRock Inc. grew its stake in USANA Health Sciences by 11.8% during the 3rd quarter. BlackRock Inc. now owns 1,076,327 shares of the company’s stock valued at $129,750,000 after acquiring an additional 113,961 shares in the last quarter. Acadian Asset Management LLC purchased a new position in USANA Health Sciences during the 2nd quarter valued at about $103,349,000. Prudential Financial Inc. grew its stake in USANA Health Sciences by 11.1% during the 3rd quarter. Prudential Financial Inc. now owns 287,082 shares of the company’s stock valued at $34,608,000 after acquiring an additional 28,659 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. grew its stake in USANA Health Sciences by 53.2% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 241,011 shares of the company’s stock valued at $29,053,000 after acquiring an additional 83,672 shares in the last quarter. Hedge funds and other institutional investors own 52.20% of the company’s stock.
Several analysts have issued reports on USNA shares. Sidoti upgraded USANA Health Sciences from a “neutral” rating to a “buy” rating in a report on Thursday, October 25th. Pivotal Research upgraded USANA Health Sciences from a “hold” rating to a “buy” rating and set a $135.00 price objective on the stock in a report on Wednesday, October 24th. Finally, ValuEngine downgraded USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Thursday.
ILLEGAL ACTIVITY WARNING: This report was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.wkrb13.com/2018/11/10/usana-health-sciences-inc-usna-insider-walter-noot-sells-363-shares.html.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.
Recommended Story: How mutual funds make money
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.